Details
Molecular Farming
Plant-made Pharmaceuticals and Technical Proteins1. Aufl.
|
160,99 € |
|
| Verlag: | Wiley-Blackwell |
| Format: | |
| Veröffentl.: | 06.03.2006 |
| ISBN/EAN: | 9783527605811 |
| Sprache: | englisch |
| Anzahl Seiten: | 338 |
DRM-geschütztes eBook, Sie benötigen z.B. Adobe Digital Editions und eine Adobe ID zum Lesen.
Beschreibungen
Here, authors from academia and industry provide an exciting overview of current production technologies and the fascinating possibilities for future applications. Topics include chloroplast-derived antibodies, biopharmaceuticals and edible vaccines, production of antibodies in plants and plant cell suspension cultures, production of spider silk proteins in plants, and glycosylation of plant produced proteins. The whole is rounded off by chapters on the demands and expectations made on molecular farming by pharmaceutical corporations and the choice of crop species in improving recombinant protein levels.<br> Of interest to biotechnologists, gene technologists, molecular biologists and protein biochemists in university as well as the biotechnological and pharmaceutical industries.
INTRODUCTION<br /> <br /> PLANT PRODUCTION TECHNOLOGIES<br /> Perennial plants as a production system for pharmaceuticals<br /> Foreign protein expression using hairy roots and plant suspension cultures<br /> Production of recombinant proteins in germinating seeds<br /> Viral expression vectors<br /> Field trials<br /> Chloroplast derived antibodies, biopharmaceuticals and edible vaccines<br /> sIgA production in plants<br /> Antibodies in plants and plant cell suspension cultures<br /> <br /> <br /> Production of spider silk proteins in plants<br /> Glycosylation of plant produced proteins<br /> The precautionary approach to tackle the wicked problems<br /> Requirements and expectations of Molecular Farming from the view of big pharma<br /> Choice of crop species and improving recombinant protein levels<br /> Gene farming in pea under field conditions: Seed specific synthesis of a bacterial exoenzyme<br />
<p>“The book will be useful for molecular biologists and protein biochemists in academia and industry with an interest in molecular pharming and for anyone interested in obtaining a quick overview of the state of the field.” (<i>Annals of Botany</i>, 1 October 2005)</p> "Authors from academia and industry provide a fascinating overview of current production technologies and possible future applications."<br /> Bioworld<br /> <br /> "... a valuable introduction. ... This volume, although aimed at a scientific audience, can be regarded as an early indication of a coming debate... Each chapter is concise but they all have many references ... I recommend this book." <br /> Chemistry & Industry<br /> <br /> "... this is an excellent book on this exciting new subject." American Journal of Therapeutics<br /> <br /> "... covers a large amount of highly detailed material in a clear and concise manner."<br /> Drug Development and Industrial Pharmacy
Prof. Dr. Rainer Fischer, 45, currently Department Head of the Institute for Molecular Biotechnology (RWTH Aachen, Germany, 80 employees) and Senior Executive Director of the Fraunhofer Institute for Molecular Biology and Applied Ecology (170 employees). His research covers many areas of Molecular Biotechnology including Genomics, Proteomics, Cellomics, Protein Engineering, Molecular Medicine, Immunology, Virology, Plant Biotechnology, as well as the Production and Purification of Recombinant Proteins.<br /> Within the last 15 years Prof. Dr. Rainer Fischer published over 90 research articles in leading international journals, 35 book chapters and established a strong global academic and industrial network. He is also well known within the scientific arenas for his international scientific talks, is on the editorial board of two highly ranked scientific journals and is reviewer for more than 20 journals. He has filed over 25 different patent applications and successfully secured more than 100 million Euros in financial support. Prof. Fischer serves as reviewer for multiple national and international grant agencies (EC, NATO and NSF), he is an adviser for four international Biotech companies and an active board member for two start-up companies.
Here, authors from academia and industry provide an exciting overview of current production technologies and the fascinating possibilities for future applications. Topics include chloroplast-derived antibodies, biopharmaceuticals and edible vaccines, production of antibodies in plants and plant cell suspension cultures, production of spider silk proteins in plants, and glycosylation of plant produced proteins. The whole is rounded off by chapters on the demands and expectations made on molecular farming by pharmaceutical corporations and the choice of crop species in improving recombinant protein levels.<br /> Of interest to biotechnologists, gene technologists, molecular biologists and protein biochemists in university as well as the biotechnological and pharmaceutical industries.
Diese Produkte könnten Sie auch interessieren:
Tropical and Parasitic Infections in the Intensive Care Unit
von: Charles Feldman, George A. Sarosi
149,79 €
